The Alliance for Clinical Trials in Oncology today announced the results of a data analysis from a randomized phase III ...
Natera, Inc. , a global leader in cell-free DNA and genetic testing, announced new data from the randomized, Phase III CALGB (Alliance) / SWOG 80702 study. The study will be presented today, Jan. 25, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback